CFG
ALNY icon

Citizens Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Citizens Financial Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
+3,682
New +$1.11M 0.01% 424
2020
Q3 		– Sell
-37
Closed -$5K – 272
2020
Q2 		$5K Hold
37
– – ﹤0.01% 882
2020
Q1 		$4K Hold
37
– – ﹤0.01% 885
2019
Q4 		$4K Buy
+37
New +$3.69K ﹤0.01% 883

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citizens Financial Group's ALNY Position: Q2 2026 in Review

Citizens Financial Group opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 3,682 shares worth $1.11M. The stake represents 0.01% of the portfolio and ranks #424 among its holdings. This is a return to the name: Citizens Financial Group previously reported a position in ALNY as recently as Q2 2020.

Citizens Financial Group first reported a position in ALNY in Q4 2019 and has held it in 4 quarters since. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Citizens Financial Group held 3,682 shares of Alnylam Pharmaceuticals worth $1.11M as of Q2 2026.
  • Alnylam Pharmaceuticals was a new Citizens Financial Group position in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.01% of Citizens Financial Group's portfolio in Q2 2026, its #424 holding.
  • Citizens Financial Group first reported a position in Alnylam Pharmaceuticals in Q4 2019 and has held it in 4 quarters since.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.